Oncology & Cancer

New bowel cancer drug starts clinical trials

Today, a new drug will become available for patients with bowel cancer as part of a national clinical trial; based on a scientific discovery made only two years ago at the CRUK/MRC Oxford Institute for Radiation Oncology.

Oncology & Cancer

Study: Enhancing cancer response to radiation

OHSU researcher Sudarshan Anand, Ph.D., has a contemporary analogy to describe microRNA: "I sometimes compare MicroRNA to tweets—they're short, transient and constantly changing."

Oncology & Cancer

Skin reactions during radiation therapy preventable

Severe skin reactions during radiation therapy could be prevented by applying a thin transparent silicone dressing to the skin from the first day of treatment, clinical research from New Zealand shows.

page 4 from 9